Citius Oncology Inc (CTOR) Stock Price, Quote & News

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 908 967 6677

Website: citiusonc.com

Address:

11 Commerce Drive, First Floor, Cranford, United States

et1000 Sep. 11 at 11:31 PM

Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $CTOR $BRLS $COHR $JOBY ERYH

0 · Reply

donein12 Sep. 8 at 1:41 PM

$CTOR Slowly and quietly CTOR is approaching a $1. Unknown if it continues to a $1. Fiscal Year End in 3 weeks.

0 · Reply

StrokemyRope Sep. 2 at 1:01 AM

SUNE moving on merger agreement. Nice action but the charts say it’s setting up for something much bigger. 3.5M float. Eyes on PM! $GURE $MITQ $CTOR

0 · Reply

HypnoTrader Aug. 28 at 11:39 AM

$CTXR $CTOR pump and dump is still going on. Hemmoraging cash. Latest sales numbers mean they probably won't be able to unlock revenue dependent additional financing from May 2026 agreement. That funding deal was horribly dilutive and not sufficient to get to profitability. Now, matters look much worse.

0 · Reply

Bren10OD Aug. 28 at 11:26 AM

$CTOR what the hell is going on here?

0 · Reply

xanadu74 Aug. 17 at 2:59 AM

$CTOR Thoughts on valuation? Assuming they keep the same (disappointingly low) rate of revenue, they will have $9.4M revenue this year. Added 29 additional sales resources, so can we expect the revenue to double next year to say $20M ? At 10x this year's revenue, they should be valued at $94M and 10x forward looking revenue, they should be at $180M valuation. At 20x (which is not uncommon based on ChatGPT) - the potential doubles. Short term down - longer term 4-5x return. Any thoughts?

0 · Reply

Jojackthewonderskunk Aug. 14 at 10:40 PM

$CTOR hosed again.

0 · Reply

Reesifer Aug. 14 at 10:28 PM

$CTOR added .72

0 · Reply

TwongStocks Aug. 14 at 8:38 PM

$CTOR $CTXR $1.5M in revenue last quarter. LOWER than the $1.7M reported for Jan-March.

3 · Reply

donein12 Aug. 14 at 3:04 PM

$CTOR 5 hours for the financials to be released, and absolutely no one is interested in CTOR based on the trading. Kinda says everything. Of course the standard excuse is investors are just waiting.However to me investors do not expect much.

1 · Reply

Market Cap	85.31M
Revenue (ttm)	0.00
Net Income (ttm)	-24.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.50

Volume	138,200
Avg Vol	89,440
Day's Range	N/A - N/A
Shares Out	92.98M
Stochastic %K	82%
Beta	3.52
Analysts	Strong Sell
Price Target	$4.00